An event is serious (FDA MedWatch definition) when the patient outcome is:deathlife-threateninghospitalisationdisabilitycongenital anomalyrequires intervention to prevent permanent impairment or damage

A 37-year-old woman died from novel influenza A (H1N1) infection, despite treatment for the illness with oseltamivir and zanamivir.

On confirmation of influenza A (H1N1) infection in hospital 12 days after symptom onset, the woman was commenced on oseltamivir 75mg twice daily. The next day, the dose was increased to 150mg twice daily and continued for 18 days. Zanamivir \[*dosage not stated*\] was then started as salvage therapy, after oseltamivir was not effective. Four doses of nebulised zanamivir 15mg was diluted in 2mL normal saline, for three days. She did not tolerate this well and the drug was stopped. Despite treatment, she developed hypoxaemia, and on hospital day 7, she started extracorporeal membrane oxygenation. Chest x-rays revealed bilateral diffuse interstitial infiltrates consistent with adult respiratory distress syndrome (ARDS). On day 12, she was found to have ventilator-associated pneumonia. *Candida albicans* was grown on a tracheal aspirate, and she was administered amphotericin B. On the same day, she developed septic shock and acute renal failure, needing inotropic support and renal replacement therapy. Nine days later, the woman experienced a tension pneumothorax and haemolysis. She died the same day.

Elevated antibody titres for influenza A were present on viral cultures, indicating recent influenza A infection. An autopsy confirmed influenza A (H1N1) infection complicated by pneumonia; the woman\'s lung showed evidence of ARDS.***Author Comment***"Our patient presented 10 days after onset of her symptoms and oseltamivir was started 12 days after symptom onset. This probably explains the rapid downhill course of her illness, despite the aggressive treatment and maximal support she was given."
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